 TherapeuticsMD, Inc. NASDAQ:TXMD Q1 2022 Earnings Conference Call May 16, 2022 4:30 PM ET Company Participants Lisa Wilson - IR Hugh ODowd - CEO Michael Donegan - Interim CFO Mark Glickman - Chief Commercial Officer Conference Call Participants Operator Good afternoon, ladies and gentlemen. Thank you for joining us for Therapeutics MDs First Quarter 2020 Financial Results Conference Call. 